Tissue Regenix moves closer to profitability after revenue jumps

Writer, Stock Market Wire
Monday, February 4, 2019 - 14:17

Regenerative medical devices company Tissue Regenix Group said it expected to move closer to its goal of generating 'sustainable profitability' in 2019 after it more than doubled its annual revenue.

Revenue for the year through December, 2018 was seen rising to £11.6m, up from £5.2m in 2017 and in line with the company's expectations.

Cash of £7.8m was better than anticipated and was driven by efficiency programmes and improved working capital management, Tissue Regenix said.

'The preliminary results for the year ended 31 December 2018 demonstrate growing commercial momentum across all of the group's operating divisions,' chairman John Samuel said.

'The group is now well-placed to deliver further organic growth and expand our commercial footprint, both with new partnerships and into new territories.'

'The board is confident that during 2019 we will continue to deliver top line revenue growth, moving closer to our goal of sustainable profitability.'

At 2:17pm: (LON:TRX) Tissue Regenix Group PLC share price was +0.33p at 6.08p

Related content

Tissue Regenix secures $20m in loan facilities

Regenerative medical devices company Tissue Regenix Group said some of its subsidiaries had agreed with MidCap Financial Trust to access a revolving credit facility and...

Tue, 04/06/2019 - 07:31

Tissue Regenix CEO to return to full-time duties after medical treatment

Regenerative medical devices company Tissue Regenix Group said chief executive Steve Couldwell would return to full time duties during June.

Couldwell had taken a leave...

Tue, 21/05/2019 - 08:25

Tissue Regenix secures additional coverage in the US for DermaPure

Tissue Regenix secured additional coverage with a US Group Purchasing Organization (GPO) for the use of DermaPure, a decellularized allograft dermis.

The company said the...

Thu, 04/04/2019 - 07:48

Tissue Regenix signs European distribution agreement with Arthrex

Regenerative medical devices company Tissue Regenix Group said it had entered into an agreement allowing Arthrex to distribute its BioRinse bone portfolio throughout Europe, with...

Tue, 13/11/2018 - 09:19

Tissue Regenix confirms new CFO appointment

Manchester-based medical devices company Tissue Regenix Group confirmed that Gareth Jones had officially taken up the role of chief financial officer.

His appointment had been...

Mon, 29/10/2018 - 07:54